ESCMID: ESGS

Aims and objectives

The ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS) focuses on the challenges posed by Staphylococcus aureus, one of the most frequent bacterial pathogens in both community and healthcare settings. With staphylococcal infections on the rise, ESGS is committed more than ever to understanding S. aureus complex pathogenesis and interactions with human hosts. Their common mission is focused on:

Coordinating pioneering fundamental and applied research across Europe in this vital area
Fostering collaboration among microbiologists, clinicians, and researchers to tackle key clinical questions, thereby turning research breakthroughs into clinical applications
Developing comprehensive guidelines to improve the diagnosis, clinical management, and prevention of staphylococcal colonisation and infection
Supporting educational initiatives at both Master's and PhD levels, cultivating the next generation of experts in this field
Strengthening the network of researchers to enhance the visibility and impact of the staphylococcal research community

Activities and resources

ESGS Newsletter, July 2025

Download

rpoB mutations and their association with rifampicin resistance in clinical Staphylococcus epidermidis

Sofie Marie Edslev, Mia Aarris, Karen Leth Nielsen, Frederik B Hertz, Thor Bech Johannesen, Camille Kolenda, Frederic Laurent, Emeli Månsson, Bo Söderquist, Marc Stegger. Journal of Antimicrobial Chemotherapy, Volume 80, Issue 4, April 2025, Pages 1067–1071

Go to publication

Antibiotic resistance and population structure of Staphylococcus epidermidis from prosthetic joint infections in Sweden and France.

Edslev SM, Laurent F, Månsson E, Johannesen TB, Aarris M, Sönksen UW, Kolenda C, Söderquist B, Stegger M. J Antimicrob Chemother. 2025 Jul 1;80(7):2007-2015

Go to publication

Reliability of disc diffusion testing and molecular epidemiology of penicillin-susceptible Staphylococcus aureus bacteraemia.

Kihlberg P, Bech Johannesen T, Stegger M, Cajander S, Söderquist B. J Antimicrob Chemother. 2025 Aug 1;80(8):2187-2193

Go to publication

From colonizer to culprit: genomic and clinical insights into S. epidermidis from post-surgical endophthalmitis.

Sagerfors S, Escobar-Herrera LA, Johannesen TB, Stegger M, Söderquist B. Eur J Clin Microbiol Infect Dis. 2025 Oct;44(10):2409-2420

Go to publication

MRSA in the community-time to take action.

Goodman AL, Lina G, Kuijper EJ. Clin Microbiol Infect. 2024 Nov 20:S1198-743X(24)00536-6

Go to publication

Niche specialization and spread of Staphylococcus capitis involved in neonatal sepsis.

Wirth T, Bergot M, Rasigade J-P, Pichon B, Barbier M, Martins-Simoes P, Jacob L, Pike R, Tissieres P, Picaud J-C, Kearns A, Supply P, Butin M, Laurent F, International Consortium for Staphylococcus capitis neonatal sepsis, ESGS Study Group of ESCMID. Nat Microbiol. 2020;5(5):735–745.

Go to publication

Implications of identifying the recently defined members of the Staphylococcus aureus complex S. argenteus and S. schweitzeri: a position paper of members of the ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS).

Becker K, Schaumburg F, Kearns A, Larsen AR, Lindsay JA, Skov RL, Westh H. Clin Microbiol Infect. 2019;25(9):1064–1070.

Go to publication

Staphylococcus aureus: Platelets – from biology to trial protocols

23 October 2025

Go to webinar

ESGS: Seminar on S. aureus microbiome & subphenotypes

25 September 2025

Go to webinar

Staphylococcus aureus: Probiotics and decolonisation; GWAS and AI

5 December 2023

Go to webinar

Staphylococcus aureus: Platelets and the SNAP trial

Go to webinar